These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 39306591)

  • 1. Correlation of sino-nasal outcome test and nasal polyp score in dupilumab-treated chronic rhinosinusitis with nasal polyps.
    Mauthe T; Ryser FS; Brühlmann C; Yalamanoglu A; Meerwein C; Steiner UC; Soyka MB
    Eur Arch Otorhinolaryngol; 2024 Sep; ():. PubMed ID: 39306591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcomes of dupilumab treatment versus endoscopic sinus surgery for chronic rhinosinusitis with nasal polyps.
    Dharmarajan H; Falade O; Lee SE; Wang EW
    Int Forum Allergy Rhinol; 2022 Aug; 12(8):986-995. PubMed ID: 34919344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening olfaction under dupilumab in chronic rhinosinusitis with nasal polyps.
    Mauthe T; Meerwein CM; Ryser FS; Brà Hlmann C; Yalamanoglu A; Steiner UC; Soyka MB
    Rhinology; 2024 Aug; 62(4):496-505. PubMed ID: 38949841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 5-Item sino-nasal outcome test and 22-item sino-nasal outcome test relationship with endoscopic and radiologic scores in chronic rhinosinusitis with nasal polyps.
    Misirovs R; Chan R; Lipworth B
    Ann Allergy Asthma Immunol; 2024 Mar; 132(3):363-367. PubMed ID: 37984707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of Dupilumab on Sinonasal Symptoms and Outcomes in Severe Chronic Rhinosinusitis With Nasal Polyps.
    Hopkins C; Mullol J; Khan AH; Lee SE; Wagenmann M; Hellings P; Fokkens W; Msihid J; Nair R; Kamat S; Nash S; Radwan A; Jacob-Nara JA; Deniz Y; Rowe PJ
    Otolaryngol Head Neck Surg; 2024 Apr; 170(4):1173-1182. PubMed ID: 38156522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mepolizumab improvements in health-related quality of life and disease symptoms in a patient population with very severe chronic rhinosinusitis with nasal polyps: psychometric and efficacy analyses from the SYNAPSE study.
    Fokkens W; Trigg A; Lee SE; Chan RH; Diamant Z; Hopkins C; Howarth P; Lund V; Mayer B; Sousa AR; Yancey S; Tabberer M;
    J Patient Rep Outcomes; 2023 Jan; 7(1):4. PubMed ID: 36662344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparative analysis of endoscopic sinus surgery versus biologics for treatment of chronic rhinosinusitis with nasal polyposis.
    Miglani A; Soler ZM; Smith TL; Mace JC; Schlosser RJ
    Int Forum Allergy Rhinol; 2023 Feb; 13(2):116-128. PubMed ID: 35980852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of Overweight on Response to Dupilumab Treatment in Chronic Rhinosinusitis with Nasal Polyps.
    Habenbacher M; Moser U; Abaira A; Tomazic PV; Kiss P; Holzmeister C; Pock J; Walla K; Lang A; Andrianakis A
    Nutrients; 2024 Sep; 16(17):. PubMed ID: 39275297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative Effectiveness of Dupilumab Versus Sinus Surgery for Chronic Rhinosinusitis With Polyps: Systematic Review and a Meta-Analysis.
    Kim DH; Stybayeva G; Hwang SH
    Am J Rhinol Allergy; 2024 Nov; 38(6):428-436. PubMed ID: 39149992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measuring Nasal Patency and the Sense of Smell in CRSwNP Patients Treated with Dupilumab.
    Ottaviano G; De Corso E; Cantone E; Ciofalo A; Saccardo T; Bernardi R; Mairani E; Montuori C; Roccuzzo G; Soldati L; Randon B; Zampollo S; Chicco AD; Visconti F; Scarpa B; Nicolai P
    J Pers Med; 2023 Jan; 13(2):. PubMed ID: 36836468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiological Versus Clinical 1-Year Outcomes of Dupilumab in Refractory CRSwNP: A Real-Life Study.
    Giombi F; Pace GM; Nappi E; Giunta G; Muci G; Pirola F; Ferreli F; Heffler E; Paoletti G; Giannitto C; Mercante G; Francone M; Spriano G; Canonica GW; Malvezzi L
    Laryngoscope; 2024 Jun; 134(6):2626-2633. PubMed ID: 38126613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of different biologics for treating chronic rhinosinusitis with nasal polyps: a network meta-analysis.
    Wang H; Xu X; Lu Z; Zhai Z; Shao L; Song X; Zhang Y
    Eur Arch Otorhinolaryngol; 2024 Aug; ():. PubMed ID: 39187717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association Between Smell Loss, Disease Burden, and Dupilumab Efficacy in Chronic Rhinosinusitis with Nasal Polyps.
    Soler ZM; Patel ZM; Mullol J; Mattos J; Nash S; Xia C; Wang Z; Borsos K; Corbett M; Jacob-Nara JA; Sacks H; Rowe P; Deniz Y; Lane AP
    Am J Rhinol Allergy; 2025 Jan; 39(1):6-12. PubMed ID: 39300794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dupilumab improves sleep quality in chronic rhinosinusitis with nasal polyps.
    Riva G; Garetto M; Borgione M; Piazza F; Prizio C; Dellea D; Albera A; Canale A; Pecorari G
    Am J Otolaryngol; 2024; 45(4):104310. PubMed ID: 38677148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Associations between the Quality of Life and Nasal Polyp Size in Patients Suffering from Chronic Rhinosinusitis without Nasal Polyps, with Nasal Polyps or Aspirin-Exacerbated Respiratory Disease.
    Schneider S; Campion NJ; Villazala-Merino S; Liu DT; Bartosik T; Landegger LD; Ahmadi N; Mueller CA; Vyskocil E; Stanek V; Quint T; Bangert C; Eckl-Dorna J
    J Clin Med; 2020 Mar; 9(4):. PubMed ID: 32231056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dupilumab Versus Mepolizumab for Chronic Rhinosinusitis With Nasal Polyposis: An Indirect Treatment Comparison.
    Hopkins C; Han JK; Fokkens W; Wagenmann M; Guyot P; Khan AH; Nash S; Wang Z; Xu Y; Msihid J; Neupane B; Nag A; Bachert C
    J Allergy Clin Immunol Pract; 2024 Dec; 12(12):3393-3401.e15. PubMed ID: 39326524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of Sinonasal Outcome Test (SNOT-22) Domains in Chronic Rhinosinusitis With Nasal Polyps.
    Khan AH; Reaney M; Guillemin I; Nelson L; Qin S; Kamat S; Mannent L; Amin N; Whalley D; Hopkins C
    Laryngoscope; 2022 May; 132(5):933-941. PubMed ID: 34437720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dupilumab (Dupixent
    Jansen F; Becker B; Eden JK; Breda PC; Hot A; Oqueka T; Betz CS; Hoffmann AS
    Eur Arch Otorhinolaryngol; 2023 Apr; 280(4):1741-1755. PubMed ID: 36242612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dupilumab Improves Outcomes in Patients with Chronic Rhinosinusitis with Nasal Polyps and Coexisting Asthma Irrespective of Baseline Asthma Characteristics.
    Busse WW; Pavord ID; Siddiqui S; Khan AH; Praestgaard A; Nash S; Jacob-Nara JA; Rowe PJ; Deniz Y
    J Asthma Allergy; 2023; 16():411-419. PubMed ID: 37096015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dupilumab in chronic rhinosinusitis with nasal polyps: Real life data in a multicentric Sicilian experience.
    Galletti C; Ragusa M; Sireci F; Ciodaro F; Barbieri MA; Giunta G; Grigaliute E; Immordino A; Lorusso F; Dispenza F; Freni F; Galletti F; Gallina S; La Mantia I; Galletti B
    Am J Otolaryngol; 2024; 45(1):104106. PubMed ID: 37948824
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.